vs

Side-by-side financial comparison of American Airlines Group Inc. (AAL) and Amgen (AMGN). Click either name above to swap in a different company.

American Airlines Group Inc. is the larger business by last-quarter revenue ($14.0B vs $8.6B, roughly 1.6× Amgen). Amgen runs the higher net margin — 21.1% vs 0.7%, a 20.4% gap on every dollar of revenue. On growth, Amgen posted the faster year-over-year revenue change (5.8% vs 2.5%). Amgen produced more free cash flow last quarter ($1.5M vs $-1.9B). Over the past eight quarters, American Airlines Group Inc.'s revenue compounded faster (5.5% CAGR vs 1.4%).

American Airlines, Inc. is a major airline in the United States headquartered in Fort Worth, Texas, within the Dallas–Fort Worth metroplex, and is the largest airline in the world in terms of passengers carried and daily flights. American, along with its regional subsidiaries and contractors operating under the brand name American Eagle, operate an extensive international and domestic network with almost 6,800 flights per day to nearly 350 destinations in 48 countries. The airline is also a f...

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.

AAL vs AMGN — Head-to-Head

Bigger by revenue
AAL
AAL
1.6× larger
AAL
$14.0B
$8.6B
AMGN
Growing faster (revenue YoY)
AMGN
AMGN
+3.3% gap
AMGN
5.8%
2.5%
AAL
Higher net margin
AMGN
AMGN
20.4% more per $
AMGN
21.1%
0.7%
AAL
More free cash flow
AMGN
AMGN
$1.9B more FCF
AMGN
$1.5M
$-1.9B
AAL
Faster 2-yr revenue CAGR
AAL
AAL
Annualised
AAL
5.5%
1.4%
AMGN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AAL
AAL
AMGN
AMGN
Revenue
$14.0B
$8.6B
Net Profit
$99.0M
$1.8B
Gross Margin
68.2%
Operating Margin
3.2%
30.9%
Net Margin
0.7%
21.1%
Revenue YoY
2.5%
5.8%
Net Profit YoY
-83.2%
EPS (diluted)
$0.15
$3.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AAL
AAL
AMGN
AMGN
Q1 26
$8.6B
Q4 25
$14.0B
$9.9B
Q3 25
$13.7B
$9.6B
Q2 25
$14.4B
$9.2B
Q1 25
$12.6B
$8.1B
Q4 24
$13.7B
$9.1B
Q3 24
$13.6B
$8.5B
Q2 24
$14.3B
$8.4B
Net Profit
AAL
AAL
AMGN
AMGN
Q1 26
$1.8B
Q4 25
$99.0M
$1.3B
Q3 25
$-114.0M
$3.2B
Q2 25
$599.0M
$1.4B
Q1 25
$-473.0M
$1.7B
Q4 24
$590.0M
$627.0M
Q3 24
$-149.0M
$2.8B
Q2 24
$717.0M
$746.0M
Gross Margin
AAL
AAL
AMGN
AMGN
Q1 26
68.2%
Q4 25
69.8%
Q3 25
67.8%
Q2 25
67.2%
Q1 25
63.6%
Q4 24
65.7%
Q3 24
61.1%
Q2 24
61.4%
Operating Margin
AAL
AAL
AMGN
AMGN
Q1 26
30.9%
Q4 25
3.2%
27.6%
Q3 25
1.1%
26.4%
Q2 25
7.9%
28.9%
Q1 25
-2.2%
14.5%
Q4 24
8.3%
25.4%
Q3 24
0.7%
24.1%
Q2 24
9.7%
22.8%
Net Margin
AAL
AAL
AMGN
AMGN
Q1 26
21.1%
Q4 25
0.7%
13.5%
Q3 25
-0.8%
33.7%
Q2 25
4.2%
15.6%
Q1 25
-3.8%
21.2%
Q4 24
4.3%
6.9%
Q3 24
-1.1%
33.3%
Q2 24
5.0%
8.9%
EPS (diluted)
AAL
AAL
AMGN
AMGN
Q1 26
$3.34
Q4 25
$0.15
$2.45
Q3 25
$-0.17
$5.93
Q2 25
$0.91
$2.65
Q1 25
$-0.72
$3.20
Q4 24
$0.94
$1.17
Q3 24
$-0.23
$5.22
Q2 24
$1.01
$1.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AAL
AAL
AMGN
AMGN
Cash + ST InvestmentsLiquidity on hand
$12.0M
Total DebtLower is stronger
$25.3B
$57.3B
Stockholders' EquityBook value
$-3.7B
$9.2B
Total Assets
$61.8B
$92.5B
Debt / EquityLower = less leverage
6.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AAL
AAL
AMGN
AMGN
Q1 26
$12.0M
Q4 25
$9.1B
Q3 25
$9.4B
Q2 25
$8.0B
Q1 25
$8.8B
Q4 24
$12.0B
Q3 24
$9.0B
Q2 24
$9.3B
Total Debt
AAL
AAL
AMGN
AMGN
Q1 26
$57.3B
Q4 25
$25.3B
$54.6B
Q3 25
$25.1B
$54.6B
Q2 25
$25.3B
$56.2B
Q1 25
$24.7B
$57.4B
Q4 24
$25.2B
$60.1B
Q3 24
$26.3B
$60.4B
Q2 24
$27.6B
$62.6B
Stockholders' Equity
AAL
AAL
AMGN
AMGN
Q1 26
$9.2B
Q4 25
$-3.7B
$8.7B
Q3 25
$-4.0B
$9.6B
Q2 25
$-3.9B
$7.4B
Q1 25
$-4.5B
$6.2B
Q4 24
$-4.0B
$5.9B
Q3 24
$-4.9B
$7.5B
Q2 24
$-4.7B
$5.9B
Total Assets
AAL
AAL
AMGN
AMGN
Q1 26
$92.5B
Q4 25
$61.8B
$90.6B
Q3 25
$62.1B
$90.1B
Q2 25
$63.7B
$87.9B
Q1 25
$62.6B
$89.4B
Q4 24
$61.8B
$91.8B
Q3 24
$63.5B
$90.9B
Q2 24
$64.1B
$90.9B
Debt / Equity
AAL
AAL
AMGN
AMGN
Q1 26
6.24×
Q4 25
6.31×
Q3 25
5.67×
Q2 25
7.57×
Q1 25
9.24×
Q4 24
10.23×
Q3 24
8.02×
Q2 24
10.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AAL
AAL
AMGN
AMGN
Operating Cash FlowLast quarter
$-274.0M
$2.2B
Free Cash FlowOCF − Capex
$-1.9B
$1.5M
FCF MarginFCF / Revenue
-13.6%
0.0%
Capex IntensityCapex / Revenue
11.6%
0.0%
Cash ConversionOCF / Net Profit
-2.77×
1.20×
TTM Free Cash FlowTrailing 4 quarters
$-680.0M
$7.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AAL
AAL
AMGN
AMGN
Q1 26
$2.2B
Q4 25
$-274.0M
$1.6B
Q3 25
$-46.0M
$4.7B
Q2 25
$963.0M
$2.3B
Q1 25
$2.5B
$1.4B
Q4 24
$398.0M
$4.8B
Q3 24
$277.0M
$3.6B
Q2 24
$1.1B
$2.5B
Free Cash Flow
AAL
AAL
AMGN
AMGN
Q1 26
$1.5M
Q4 25
$-1.9B
$961.0M
Q3 25
$-872.0M
$4.2B
Q2 25
$464.0M
$1.9B
Q1 25
$1.6B
$980.0M
Q4 24
$-342.0M
$4.4B
Q3 24
$-191.0M
$3.3B
Q2 24
$477.0M
$2.2B
FCF Margin
AAL
AAL
AMGN
AMGN
Q1 26
0.0%
Q4 25
-13.6%
9.7%
Q3 25
-6.4%
44.4%
Q2 25
3.2%
20.8%
Q1 25
13.0%
12.0%
Q4 24
-2.5%
48.4%
Q3 24
-1.4%
39.0%
Q2 24
3.3%
26.5%
Capex Intensity
AAL
AAL
AMGN
AMGN
Q1 26
0.0%
Q4 25
11.6%
6.5%
Q3 25
6.0%
4.6%
Q2 25
3.5%
4.0%
Q1 25
6.6%
5.0%
Q4 24
5.4%
4.1%
Q3 24
3.4%
3.0%
Q2 24
4.5%
2.8%
Cash Conversion
AAL
AAL
AMGN
AMGN
Q1 26
1.20×
Q4 25
-2.77×
1.20×
Q3 25
1.46×
Q2 25
1.61×
1.59×
Q1 25
0.80×
Q4 24
0.67×
7.61×
Q3 24
1.26×
Q2 24
1.57×
3.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AAL
AAL

Passenger Travel$11.6B83%
Loyalty Program Travel Redemptions$1.1B8%
Loyalty Program Marketing Services$945.0M7%
Cargo And Freight$227.0M2%
Other Revenue$169.0M1%

AMGN
AMGN

Product sales$8.2B95%
Other revenues$400.0M5%

Related Comparisons